Fruquintinib beneficial in elderly patient with neoplastic pericardial effusion from rectal cancer: A case report

BACKGROUND: Neoplastic pericardial effusion (NPE) is a rare consequence of rectal cancer and carries a poor prognosis. Optimal management has yet to be determined. Fruquintinib is an oral anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor approved by the China Food and Drug A...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ying, Zou, Jia-Yun, Xu, Yan-Yan, He, Jing-Ni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316928/
https://www.ncbi.nlm.nih.gov/pubmed/34368339
http://dx.doi.org/10.12998/wjcc.v9.i21.6170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316928/
https://www.ncbi.nlm.nih.gov/pubmed/34368339
http://dx.doi.org/10.12998/wjcc.v9.i21.6170

Ejemplares similares